tradingkey.logo


tradingkey.logo


Elevance Health Inc

ELV
296.090USD
+5.760+1.98%
āļ›āļīāļ” 03/25, 16:00ETāļĢāļēāļ„āļēāļĨāđˆāļēāļŠāđ‰āļē 15 āļ™āļēāļ—āļĩ
98.24BāļĄāļđāļĨāļ„āđˆāļēāļ•āļĨāļēāļ”
11.71P/E TTM


āļĢāļēāļĒāļĨāļ°āđ€āļ­āļĩāļĒāļ”āđ€āļžāļīāđˆāļĄāđ€āļ•āļīāļĄāļ‚āļ­āļ‡ Elevance Health Inc āļšāļĢāļīāļĐāļąāļ—

Elevance Health, Inc. is a health company. It operates as a health insurer in the United States. The Company operates through four segments: Health Benefits, CarelonRx, Carelon Services and Corporate & Other. The Health Benefits segment offers a comprehensive suite of health plans and services to its Individual, Employer Group risk-based, Employer Group fee-based, BlueCard, Medicare, Medicaid and Federal Employee Program (FEP) members. The Health Benefits segment also offers health products on a full-risk basis. The CarelonRx segment includes its pharmacy services business. CarelonRx markets and offers pharmacy services to its affiliated health plan customers, as well as to external customers outside of the health plans. The Carelon Services segment integrates physical, behavioral, pharmacy, and social services by offering an array of healthcare-related services and capabilities to internal and external customers through its Carelon Health and Carelon Insights businesses.

āļ‚āđ‰āļ­āļĄāļđāļĨ Elevance Health Inc


āļŠāļąāļāļĨāļąāļāļĐāļ“āđŒāļĒāđˆāļ­āļ‚āļ­āļ‡āļŦāļļāđ‰āļ™ELV
āļŠāļ·āđˆāļ­āļšāļĢāļīāļĐāļąāļ—Elevance Health Inc
āļ§āļąāļ™āļ—āļĩāđˆāđ€āļŠāļ™āļ­āļ‚āļēāļĒāļ„āļĢāļąāđ‰āļ‡āđāļĢāļOct 30, 2001
āļ‹āļĩāļ­āļĩāđ‚āļ­Boudreaux (Gail K)
āļˆāļģāļ™āļ§āļ™āļžāļ™āļąāļāļ‡āļēāļ™103158
āļ›āļĢāļ°āđ€āļ āļ—āļāļēāļĢāļĢāļąāļāļĐāļēāļ„āļ§āļēāļĄāļ›āļĨāļ­āļ”āļ āļąāļĒOrdinary Share
āļŠāļīāđ‰āļ™āļ›āļĩāļ‡āļšāļ›āļĢāļ°āļĄāļēāļ“Oct 30
āļ—āļĩāđˆāļ­āļĒāļđāđˆ220 Virginia Avenue
āđ€āļĄāļ·āļ­āļ‡INDIANAPOLIS
āļ•āļĨāļēāļ”āļŦāļĨāļąāļāļ—āļĢāļąāļžāļĒāđŒNASDAQ OMX NASDAQ Basic NYSE
āļ›āļĢāļ°āđ€āļ—āļĻUnited States of America
āļĢāļŦāļąāļŠāđ„āļ›āļĢāļĐāļ“āļĩāļĒāđŒ46204
āđ‚āļ—āļĢāļĻāļąāļžāļ—āđŒ18003311476
āđ€āļ§āđ‡āļšāđ„āļ‹āļ•āđŒhttps://www.elevancehealth.com/
āļŠāļąāļāļĨāļąāļāļĐāļ“āđŒāļĒāđˆāļ­āļ‚āļ­āļ‡āļŦāļļāđ‰āļ™ELV
āļ§āļąāļ™āļ—āļĩāđˆāđ€āļŠāļ™āļ­āļ‚āļēāļĒāļ„āļĢāļąāđ‰āļ‡āđāļĢāļOct 30, 2001
āļ‹āļĩāļ­āļĩāđ‚āļ­Boudreaux (Gail K)

āļœāļđāđ‰āļšāļĢāļīāļŦāļēāļĢāļšāļĢāļīāļĐāļąāļ—āļ‚āļ­āļ‡ Elevance Health Inc


āļŠāļ·āđˆāļ­
āļŠāļ·āđˆāļ­/āļ•āļģāđāļŦāļ™āđˆāļ‡
āļ•āļģāđāļŦāļ™āđˆāļ‡
āļāļēāļĢāļ–āļ·āļ­āļŦāļļāđ‰āļ™
āđ€āļ›āļĨāļĩāđˆāļĒāļ™
Mr. Ramiro G. Peru
Mr. Ramiro G. Peru
Independent Chairman of the Board
Independent Chairman of the Board
9.35K
+6.43%
Mr. Antonio F. Neri
Mr. Antonio F. Neri
Independent Director
Independent Director
4.92K
+12.20%
Dr. Bahija Jallal, Ph.D.
Dr. Bahija Jallal, Ph.D.
Independent Director
Independent Director
4.79K
+12.55%
Mr. Ronald W. Penczek
Mr. Ronald W. Penczek
Chief Accounting Officer, Controller
Chief Accounting Officer, Controller
3.92K
+56.79%
Ms. Deanna D. Strable-Soethout
Ms. Deanna D. Strable-Soethout
Independent Director
Independent Director
1.65K
+36.51%
Mr. Robert L. Dixon, Jr.
Mr. Robert L. Dixon, Jr.
Independent Director
Independent Director
--
--
Mr. Lewis (Lew) Hay, III
Mr. Lewis (Lew) Hay, III
Independent Director
Independent Director
--
--
Mr. Peter D. (Pete) Haytaian
Mr. Peter D. (Pete) Haytaian
Executive Vice President and President, Carelon and CarelonRx
Executive Vice President and President, Carelon and CarelonRx
--
--
Mr. R. Kerry Clark
Mr. R. Kerry Clark
Independent Director
Independent Director
--
--
Ms. Gail K. Boudreaux
Ms. Gail K. Boudreaux
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
āļ”āļđāđ€āļžāļīāđˆāļĄāđ€āļ•āļīāļĄ
āļŠāļ·āđˆāļ­
āļŠāļ·āđˆāļ­/āļ•āļģāđāļŦāļ™āđˆāļ‡
āļ•āļģāđāļŦāļ™āđˆāļ‡
āļāļēāļĢāļ–āļ·āļ­āļŦāļļāđ‰āļ™
āđ€āļ›āļĨāļĩāđˆāļĒāļ™
Mr. Ramiro G. Peru
Mr. Ramiro G. Peru
Independent Chairman of the Board
Independent Chairman of the Board
9.35K
+6.43%
Mr. Antonio F. Neri
Mr. Antonio F. Neri
Independent Director
Independent Director
4.92K
+12.20%
Dr. Bahija Jallal, Ph.D.
Dr. Bahija Jallal, Ph.D.
Independent Director
Independent Director
4.79K
+12.55%
Mr. Ronald W. Penczek
Mr. Ronald W. Penczek
Chief Accounting Officer, Controller
Chief Accounting Officer, Controller
3.92K
+56.79%
Ms. Deanna D. Strable-Soethout
Ms. Deanna D. Strable-Soethout
Independent Director
Independent Director
1.65K
+36.51%
Mr. Robert L. Dixon, Jr.
Mr. Robert L. Dixon, Jr.
Independent Director
Independent Director
--
--

āļŠāļąāļ”āļŠāđˆāļ§āļ™āļ‚āļ­āļ‡āļĢāļēāļĒāđ„āļ”āđ‰

FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
āļ•āļēāļĄāļ˜āļļāļĢāļāļīāļˆUSD
āļŠāļ·āđˆāļ­
āļĢāļēāļĒāđ„āļ”āđ‰
āļŠāļąāļ”āļŠāđˆāļ§āļ™
Premiums
41.79B
0.00%
Product revenue
6.16B
0.00%
Service fees
2.14B
0.00%
Reconciliation
624.00M
0.00%
Operating revenue - affliated
0.00
0.00%
āļ‚āđ‰āļ­āļĄāļđāļĨāļ—āļĩāđˆāđ€āļāļĩāđˆāļĒāļ§āļ‚āđ‰āļ­āļ‡āļĒāļąāļ‡āđ„āļĄāđˆāđ„āļ”āđ‰āļĢāļąāļšāļāļēāļĢāđ€āļ›āļīāļ”āđ€āļœāļĒāļˆāļēāļāļ—āļēāļ‡āļšāļĢāļīāļĐāļąāļ—
āļ•āļēāļĄāļ˜āļļāļĢāļāļīāļˆ
āļ•āļēāļĄāļ āļđāļĄāļīāļ āļēāļ„
āļ•āļēāļĄāļ˜āļļāļĢāļāļīāļˆUSD
āļŠāļ·āđˆāļ­
āļĢāļēāļĒāđ„āļ”āđ‰
āļŠāļąāļ”āļŠāđˆāļ§āļ™
Premiums
41.79B
0.00%
Product revenue
6.16B
0.00%
Service fees
2.14B
0.00%
Reconciliation
624.00M
0.00%
Operating revenue - affliated
0.00
0.00%

āļŠāļ–āļīāļ•āļīāļāļēāļĢāļ–āļ·āļ­āļŦāļļāđ‰āļ™

āļ­āļąāļ›āđ€āļ”āļ•āđ€āļĄāļ·āđˆāļ­: āļ§āļąāļ™āļˆāļąāļ™āļ—āļĢāđŒāļ—āļĩāđˆ 16 āļ.āļž.
āļ­āļąāļ›āđ€āļ”āļ•āđ€āļĄāļ·āđˆāļ­: āļ§āļąāļ™āļˆāļąāļ™āļ—āļĢāđŒāļ—āļĩāđˆ 16 āļ.āļž.
āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™
āļ›āļĢāļ°āđ€āļ āļ—āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™
āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™
āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™
āļŠāļąāļ”āļŠāđˆāļ§āļ™
The Vanguard Group, Inc.
10.38%
BlackRock Institutional Trust Company, N.A.
5.33%
State Street Investment Management (US)
4.69%
Wellington Management Company, LLP
3.76%
T. Rowe Price Associates, Inc.
3.23%
āļ­āļ·āđˆāļ™ āđ†
72.63%
āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™
āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™
āļŠāļąāļ”āļŠāđˆāļ§āļ™
The Vanguard Group, Inc.
10.38%
BlackRock Institutional Trust Company, N.A.
5.33%
State Street Investment Management (US)
4.69%
Wellington Management Company, LLP
3.76%
T. Rowe Price Associates, Inc.
3.23%
āļ­āļ·āđˆāļ™ āđ†
72.63%
āļ›āļĢāļ°āđ€āļ āļ—āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™
āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™
āļŠāļąāļ”āļŠāđˆāļ§āļ™
Investment Advisor
50.03%
Investment Advisor/Hedge Fund
32.48%
Hedge Fund
2.77%
Pension Fund
2.59%
Bank and Trust
2.20%
Research Firm
1.79%
Sovereign Wealth Fund
1.44%
Family Office
0.27%
Family Office
0.27%
āļ­āļ·āđˆāļ™ āđ†
6.16%

āļāļēāļĢāļ–āļ·āļ­āļŦāļļāđ‰āļ™āļ‚āļ­āļ‡āļŠāļ–āļēāļšāļąāļ™


āļ­āļąāļ›āđ€āļ”āļ•āđ€āļĄāļ·āđˆāļ­: āļ§āļąāļ™āļˆāļąāļ™āļ—āļĢāđŒāļ—āļĩāđˆ 8 āļ˜.āļ„.
āļ­āļąāļ›āđ€āļ”āļ•āđ€āļĄāļ·āđˆāļ­: āļ§āļąāļ™āļˆāļąāļ™āļ—āļĢāđŒāļ—āļĩāđˆ 8 āļ˜.āļ„.
āļŠāđˆāļ§āļ‡āđ€āļ§āļĨāļēāļāļēāļĢāļĢāļēāļĒāļ‡āļēāļ™
āļˆāļģāļ™āļ§āļ™āļŠāļ–āļēāļšāļąāļ™
āļŦāļļāđ‰āļ™āļ—āļĩāđˆāļ–āļ·āļ­āļ„āļĢāļ­āļ‡
āļŠāļąāļ”āļŠāđˆāļ§āļ™
āđ€āļ›āļĨāļĩāđˆāļĒāļ™
2025Q4
3063
205.92M
97.95%
+22.74K
2025Q3
3138
205.95M
97.05%
-3.45M
2025Q2
3116
209.73M
96.68%
-566.57K
2025Q1
3115
208.90M
96.86%
-10.38M
2024Q4
3105
212.00M
93.76%
+298.05K
2024Q3
2993
212.22M
94.67%
-2.15M
2024Q2
2959
214.26M
94.25%
+1.04M
2024Q1
2925
213.00M
94.22%
-6.19M
2023Q4
2869
213.96M
93.90%
-1.80M
2023Q3
2746
215.71M
93.86%
-2.17M
āļ”āļđāđ€āļžāļīāđˆāļĄāđ€āļ•āļīāļĄ

āļāļīāļˆāļāļĢāļĢāļĄāļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™


āļŠāļ·āđˆāļ­
āļŦāļļāđ‰āļ™āļ—āļĩāđˆāļ–āļ·āļ­āļ„āļĢāļ­āļ‡
āļŠāļąāļ”āļŠāđˆāļ§āļ™
āđ€āļ›āļĨāļĩāđˆāļĒāļ™
āđ€āļ›āļĨāļĩāđˆāļĒāļ™%
āļ§āļąāļ™āļ—āļĩāđˆ
The Vanguard Group, Inc.
22.88M
10.3%
+133.40K
+0.59%
Sep 30, 2025
BlackRock Institutional Trust Company, N.A.
11.81M
5.31%
+190.00K
+1.64%
Sep 30, 2025
State Street Investment Management (US)
10.35M
4.66%
-222.81K
-2.11%
Sep 30, 2025
Wellington Management Company, LLP
6.62M
2.98%
+303.10K
+4.80%
Sep 30, 2025
T. Rowe Price Associates, Inc.
5.50M
2.48%
-2.25M
-29.00%
Sep 30, 2025
Sanders Capital, LLC
5.77M
2.6%
-56.29K
-0.97%
Sep 30, 2025
Geode Capital Management, L.L.C.
5.14M
2.31%
+50.02K
+0.98%
Sep 30, 2025
Artisan Partners Limited Partnership
4.58M
2.06%
+901.63K
+24.53%
Sep 30, 2025
Harris Associates L.P.
3.19M
1.44%
+902.06K
+39.43%
Sep 30, 2025
First Eagle Investment Management, L.L.C.
4.00M
1.8%
+798.46K
+24.95%
Sep 30, 2025
āļ”āļđāđ€āļžāļīāđˆāļĄāđ€āļ•āļīāļĄ

ETF āļ—āļĩāđˆāđ€āļāļĩāđˆāļĒāļ§āļ‚āđ‰āļ­āļ‡


āļ­āļąāļ›āđ€āļ”āļ•āđ€āļĄāļ·āđˆāļ­: āļ§āļąāļ™āđ€āļŠāļēāļĢāđŒāļ—āļĩāđˆ 6 āļ˜.āļ„.
āļ­āļąāļ›āđ€āļ”āļ•āđ€āļĄāļ·āđˆāļ­: āļ§āļąāļ™āđ€āļŠāļēāļĢāđŒāļ—āļĩāđˆ 6 āļ˜.āļ„.
āļŠāļ·āđˆāļ­
āļŠāļąāļ”āļŠāđˆāļ§āļ™
iShares U.S. Healthcare Providers ETF
4.43%
Monarch Dividend Plus Index ETF
3.25%
John Hancock Fundamental All Cap Core ETF
2.45%
GMO US Quality ETF
2.35%
VictoryShares Free Cash Flow ETF
2.32%
Bushido Capital US Equity ETF
2.2%
State Street SPDR S&P Health Care Services ETF
2.11%
First Eagle Global Equity ETF
2.03%
First Trust Total US Market AlphaDEX ETF
1.75%
First Trust Health Care Alphadex Fund
1.71%
āļ”āļđāđ€āļžāļīāđˆāļĄāđ€āļ•āļīāļĄ
iShares U.S. Healthcare Providers ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™4.43%
Monarch Dividend Plus Index ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™3.25%
John Hancock Fundamental All Cap Core ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™2.45%
GMO US Quality ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™2.35%
VictoryShares Free Cash Flow ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™2.32%
Bushido Capital US Equity ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™2.2%
State Street SPDR S&P Health Care Services ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™2.11%
First Eagle Global Equity ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™2.03%
First Trust Total US Market AlphaDEX ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™1.75%
First Trust Health Care Alphadex Fund
āļŠāļąāļ”āļŠāđˆāļ§āļ™1.71%

āđ€āļ‡āļīāļ™āļ›āļąāļ™āļœāļĨ


āļĄāļĩāļāļēāļĢāļˆāđˆāļēāļĒāđ€āļ‡āļīāļ™āļ›āļąāļ™āļœāļĨāđ€āļ›āđ‡āļ™āļˆāļģāļ™āļ§āļ™āļĢāļ§āļĄ 5.24B USD āđƒāļ™āļŠāđˆāļ§āļ‡ 5 āļ›āļĩāļ—āļĩāđˆāļœāđˆāļēāļ™āļĄāļē
āļ§āļąāļ™āļ—āļĩāđˆ
āđ€āļ‡āļīāļ™āļ›āļąāļ™āļœāļĨ
āļ§āļąāļ™āļ—āļĩāđˆāļšāļąāļ™āļ—āļķāļ
āļ§āļąāļ™āļ—āļĩāđˆāļŠāļģāļĢāļ°āđ€āļ‡āļīāļ™
āļ§āļąāļ™āļ—āļĩāđˆāđ„āļĄāđˆāđ„āļ”āđ‰āļĢāļąāļšāļŠāļīāļ—āļ˜āļīāļ›āļąāļ™āļœāļĨ
Jan 28, 2026
ELV.NB Interim Cash Dividend of gross USD 1.72 paid on Mar 25, 2026 going ex on Mar 10, 2026
Mar 10, 2026
Mar 25, 2026
Mar 10, 2026
Oct 15, 2025
ELV.NB Final Cash Dividend of gross USD 1.71 paid on Dec 19, 2025 going ex on Dec 05, 2025
Dec 05, 2025
Dec 19, 2025
Dec 05, 2025
Jul 17, 2025
ELV.NB Interim Cash Dividend of gross USD 1.71 paid on Sep 25, 2025 going ex on Sep 10, 2025
Sep 10, 2025
Sep 25, 2025
Sep 10, 2025
Apr 22, 2025
ELV.NB Interim Cash Dividend of gross USD 1.71 paid on Jun 25, 2025 going ex on Jun 10, 2025
Jun 10, 2025
Jun 25, 2025
Jun 10, 2025
Jan 23, 2025
ELV.NB Interim Cash Dividend of gross USD 1.71 paid on Mar 25, 2025 going ex on Mar 10, 2025
Mar 10, 2025
Mar 25, 2025
Mar 10, 2025
Oct 17, 2024
ELV.NB Final Cash Dividend of gross USD 1.63 paid on Dec 20, 2024 going ex on Dec 05, 2024
Dec 05, 2024
Dec 20, 2024
Dec 05, 2024
Jul 17, 2024
ELV.NB Interim Cash Dividend of gross USD 1.63 paid on Sep 25, 2024 going ex on Sep 10, 2024
Sep 10, 2024
Sep 25, 2024
Sep 10, 2024
Apr 18, 2024
ELV.NB Interim Cash Dividend of gross USD 1.63 paid on Jun 25, 2024 going ex on Jun 10, 2024
Jun 10, 2024
Jun 25, 2024
Jun 10, 2024
Jan 26, 2024
ELV.NB Interim Cash Dividend of gross USD 1.63 paid on Mar 22, 2024 going ex on Mar 07, 2024
Mar 08, 2024
Mar 22, 2024
Mar 07, 2024
Oct 18, 2023
ELV.NB Final Cash Dividend of gross USD 1.48 paid on Dec 21, 2023 going ex on Dec 05, 2023
Dec 06, 2023
Dec 21, 2023
Dec 05, 2023
āļ”āļđāđ€āļžāļīāđˆāļĄāđ€āļ•āļīāļĄ

āļāļēāļĢāđāļšāđˆāļ‡āļŦāļļāđ‰āļ™


āļ§āļąāļ™āļ—āļĩāđˆ
āļ§āļąāļ™āļ—āļĩāđˆāđ„āļĄāđˆāđ„āļ”āđ‰āļĢāļąāļšāļŠāļīāļ—āļ˜āļīāļ›āļąāļ™āļœāļĨ
āļ›āļĢāļ°āđ€āļ āļ—
āļ­āļąāļ•āļĢāļēāļŠāđˆāļ§āļ™
āđ„āļĄāđˆāļĄāļĩāļ‚āđ‰āļ­āļĄāļđāļĨ
āļ§āļąāļ™āļ—āļĩāđˆ
āļ§āļąāļ™āļ—āļĩāđˆāđ„āļĄāđˆāđ„āļ”āđ‰āļĢāļąāļšāļŠāļīāļ—āļ˜āļīāļ›āļąāļ™āļœāļĨ
āļ›āļĢāļ°āđ€āļ āļ—
āļ­āļąāļ•āļĢāļēāļŠāđˆāļ§āļ™
āđ„āļĄāđˆāļĄāļĩāļ‚āđ‰āļ­āļĄāļđāļĨ
KeyAI
î™